In contrast, at the protein level, CDK19 expression in tumor cell lines (other than prostate cancer) is generally much lower than the expression of CDK8 (our unpublished data), suggesting post-transcriptional regulation of CDK19. The gene discussed is CDK8; the disease is prostate carcinoma.